Observational study / 2013
Pre-diagnosis phytoestrogen intake was not significantly associated with factors linked to improved breast cancer prognosis in UK women.
The DietCompLyf study evaluated associations between pre-diagnosis phytoestrogen consumption (isoflavones and lignans via food frequency questionnaire) and breast cancer risk and prognostic factors in 1,797 women. Isoflavone intakes were higher in patients who were younger at diagnosis, non-smokers, had breast-fed, and took supplements. Lignan intakes were higher in older patients, ex-smokers, supplement users, those who breast-fed, were nulliparous, had lower BMI, and younger age at menarche. No significant associations were observed between pre-diagnosis phytoestrogen intake and factors associated with improved breast cancer prognosis.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 1,797 women with grade I-III breast cancer (from a cohort of 3,159 recruited in the UK)
- What was measured
- Associations between pre-diagnosis phytoestrogen intake and breast cancer risk/prognostic factors
THE PAPER
The DietCompLyf study: a prospective cohort study of breast cancer survival and phytoestrogen consumption.
Swann R, Perkins KA, Velentzis LS, Ciria C, Dutton SJ, Mulligan AA, Woodside JV, Cantwell MM, Leathem AJ, Robertson CE, Dwek MV. Maturitas, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.